REFERENCES
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.
2. Manabe N, Matsueda K, Haruma K. Epidemiological review of gastroesophageal junction adenocarcinoma in Asian countries. Digestion 2022;103:29-36.
3. Ozawa S, Uchi Y, Ando T, Hayashi K, Aoki T. Essential updates 2020/2021: recent topics in surgery and perioperative therapy for esophageal cancer. Ann Gastroenterol Surg 2023;7:346-57.
4. Booka E, Takeuchi H, Kikuchi H, et al. Recent advances in thoracoscopic esophagectomy for esophageal cancer. Asian J Endosc Surg 2019;12:19-29.
5. Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol 2017;24:1821-7.
6. Booka E, Kikuchi H, Haneda R, et al. Short-term outcomes of robot-assisted minimally invasive esophagectomy compared with thoracoscopic or transthoracic esophagectomy. Anticancer Res 2021;41:4455-62.
7. Kikuchi H, Hiramatsu Y, Matsumoto T, et al. The hybrid position is superior to the prone position for thoracoscopic esophagectomy with upper mediastinal lymphadenectomy. Ann Laparosc Endosc Surg 2020;5:13.
8. Hosoda K, Niihara M, Harada H, Yamashita K, Hiki N. Robot-assisted minimally invasive esophagectomy for esophageal cancer: meticulous surgery minimizing postoperative complications. Ann Gastroenterol Surg 2020;4:608-17.
9. van der Horst S, Weijs TJ, Braunius WW, et al. Safety and feasibility of robot-assisted minimally invasive esophagectomy (RAMIE) with three-field lymphadenectomy and neoadjuvant chemoradiotherapy in patients with resectable esophageal cancer and cervical lymph node metastasis. Ann Surg Oncol 2023;30:2743-52.
10. van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg 2019;269:621-30.
11. Yang Y, Li B, Yi J, et al. Robot-assisted versus conventional minimally invasive esophagectomy for resectable esophageal squamous cell carcinoma: early results of a multicenter randomized controlled trial: the RAMIE trial. Ann Surg 2022;275:646-53.
12. Chao YK, Li ZG, Wen YW, et al. Robotic-assisted esophagectomy vs video-assisted thoracoscopic esophagectomy (REVATE): study protocol for a randomized controlled trial. Trials 2019;20:346.
13. Haneda R, Kikuchi H, Nagakura Y, et al. Development and validation of the optimal circumferential resection margin in pathological T3 esophageal cancer: a multicenter, retrospective study. Ann Surg Oncol 2022;29:4452-61.
14. Okada N, Fujii S, Fujita T, et al. The prognostic significance of the positive circumferential resection margin in pathologic T3 squamous cell carcinoma of the esophagus with or without neoadjuvant chemotherapy. Surgery 2016;159:441-50.
15. Evans R, Bundred JR, Kaur P, Hodson J, Griffiths EA. Meta-analysis of the influence of a positive circumferential resection margin in oesophageal cancer. BJS Open 2019;3:595-605.
